For females ≥18 years with a GPV in BRCA1, BRCA2 or PALB2, a referral to the very high-risk breast cancer screening (VHRS) programme or equivalent should be made at the time of diagnosis. The gene discussed is PALB2; the disease is breast carcinoma.